Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |